MedTrace Logo

Efficacy of KOVIR Capsule in the Combination Regimen With Background Treatment in COVID-19 Patients

NCT05044650 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2022-02-04

No results posted yet for this study

Summary

The acute pneumonia pandemic caused by a new strain of corona virus 2019, namely as COVID-19 by the World Health Organization (WHO), is a pandemic caused by SARS-CoV-2 virus. The reported symptoms vary from fever or chills, cough, shortness of breath, to muscle aches, headaches, loss of taste or smell.

The capsule KOVIR is a product based on the traditional medicine named "Ren shen bai du san" which is used to treat the cold conditions, also known as the initial plague according to the theory of traditional medicine.

Conditions

Interventions

DIETARY_SUPPLEMENT

KOVIR capsule combined with background treatment

KOVIR is a hard capsule containing fine powder mixed medicinal herbs 600 mg

Sponsors & Collaborators

  • Big Leap Research

    collaborator OTHER

  • Sao Thai Duong Joint Stock Company

    lead INDUSTRY

Principal Investigators

  • Loc Huynh, SL II., MD. · Traditional Medicine Institute in Ho Chi Minh City

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05044650 on ClinicalTrials.gov